Veeva Systems Inc (NYSE:VEEV)’ latest release of Veeva CRM Mobile this month will natively support Microsoft Windows 10. Through its partnership with Microsoft Corporation (NASDAQ:MSFT), Veeva developed Veeva CRM for Windows 10 ahead of Microsoft’s July 29 release, ensuring customers can fully leverage the new operating system as soon as it is available.

Veeva’s underlying multitenant cloud architecture allows for this type of continuous innovation and rapid time to value. And the company’s industry cloud focus ensures its solutions are tailored to fit life sciences’ unique needs and regulatory requirements.

“With technologies and markets changing at an incredible pace, Veeva has always allowed Depomed to stay a step ahead,” said Mark Howard, senior director of IT at Depomed. Depomed’s field sales reps have been leveraging Veeva CRM Mobile for Windows 8 since introduced in 2013. “With Veeva, we are not responsible for shouldering either the cost or resources tied to supporting new platforms and upgrades. Veeva is evolving with our growing business as new and enhanced capabilities allow our teams in the field to make accurate and efficient decisions time after time.”

Native support for Windows 10 will provide an enhanced user experience. Veeva CRM Approved Email, for instance, will get a boost from Windows 10’s new dictation-driven email capability. Meanwhile, applications like Veeva CRM Engage and Veeva CRM CoBrowse will benefit from animation upgrades that will improve eDetailing sessions with physicians.

“We are excited Veeva is proactively supporting Windows 10, allowing our joint customers to be among the first to move to our new operating system,” said Craig Dewar, senior director of product marketing for Windows at Microsoft. “Veeva CRM combined with Windows tablets enable life sciences sales reps to be productive and secure on a single, mobile device.”

Veeva first introduced its Windows 8, touchscreen-optimized Veeva CRM Mobile solution in 2013 to provide life sciences companies with the freedom to choose among a range of tablets. “We are committed to optimizing Veeva CRM for key mobile devices and platforms so our customers have the choice to use the technology that works best for their needs,” said Brian Longo, general manager of commercial products atVeeva. “Now, Veeva CRM runs on the latest operating systems for both Apple and Windows.”

The latest release of Veeva CRM with Windows 10 support is now available to customers. (Original Source)

Shares of Veeva Systems Inc closed yesterday at $27.1 . VEEV has a 1-year high of $33.66 and a 1-year low of $21.57. The stock’s 50-day moving average is $27.70 and its 200-day moving average is $27.70.

On the ratings front, Canaccord Genuity analyst Richard Davis maintained a Buy rating on VEEV, with a price target of $36, in a report issued on May 29. The current price target represents a potential upside of 32.8% from where the stock is currently trading.

According to, Davis has a total average return of 5.7%, a 54.7% success rate, and is ranked #526 out of 3718 analysts.

Veeva Systems Inc is a provider of industry-specific, cloud-based software solutions for the life sciences industry.